» Articles » PMID: 24741124

High-Intensity Focused Ultrasound Ablation of Uterine Fibroids - Potential Impact on Fertility and Pregnancy Outcome

Overview
Date 2014 Apr 18
PMID 24741124
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Laparoscopic myomectomy is regarded as the gold standard for women with symptomatic fibroids who wish to become pregnant. High-intensity focused ultrasound (HIFU or MRgFUS) ablation of uterine fibroids is also being discussed as a non-surgical, minimally invasive, therapeutic option. This review examines the available data on the impact of HIFU/MRgFUS on fertility and pregnancy, focusing particularly on potential direct side-effects of this type of intervention on ovaries, fallopian tubes and uterus and potential late effects on pregnancy and birth, based on the current literature. All pregnancies after HIFU/MRgFUS published to date (around 100 cases) were evaluated. The published case series suggest that HIFU/MRgFUS ablation has no impact on the rate of miscarriages or other obstetrical outcome parameters. Because no prospective studies exist which permit firm conclusions to be drawn on the impact of HIFU/MRgFUS on fertility and pregnancy outcome in women with symptomatic fibroids, this approach is currently only recommended for women with suspected fertility problems due to uterine fibroids who either decline surgery or who have an unacceptably high surgical risk.

Citing Articles

An Updated Review of Thermal Ablation Technology for Uterine Fibroids and Adenomyosis: Focusing on Protecting Fertility.

Zhang Q, Liang X, Chen Z Int J Womens Health. 2024; 16:1551-1563.

PMID: 39346931 PMC: 11430362. DOI: 10.2147/IJWH.S473005.


What predicts durable symptom relief of uterine fibroids treated with MRI-guided focused ultrasound? A multicenter trial in 8 academic centers.

Bitton R, Fast A, Vu K, Lum D, Chen B, Hesley G Eur Radiol. 2023; 33(11):7360-7370.

PMID: 37553488 DOI: 10.1007/s00330-023-09984-4.


Intravoxel incoherent motion diffusion-weighted MRI for predicting the efficacy of high-intensity focused ultrasound ablation for uterine fibroids.

Jiang Y, Qin S, Wang Y, Liu Y, Liu N, Tang L Front Oncol. 2023; 13:1178649.

PMID: 37427113 PMC: 10324408. DOI: 10.3389/fonc.2023.1178649.


Review of Robot-Assisted HIFU Therapy.

Gunderman A, Montayre R, Ranjan A, Chen Y Sensors (Basel). 2023; 23(7).

PMID: 37050766 PMC: 10098661. DOI: 10.3390/s23073707.


Ultrasonic Enhancement of Chondrogenesis in Mesenchymal Stem Cells by Bolt-Clamped Langevin Transducers.

Kim J, Bae H, Han H, Lee J Micromachines (Basel). 2023; 14(1).

PMID: 36677263 PMC: 9865917. DOI: 10.3390/mi14010202.


References
1.
Hoellen F, Griesinger G, Bohlmann M . Therapeutic drugs in the treatment of symptomatic uterine fibroids. Expert Opin Pharmacother. 2013; 14(15):2079-85. DOI: 10.1517/14656566.2013.825607. View

2.
David M, Kroncke T . Uterine Fibroid Embolisation - Potential Impact on Fertility and Pregnancy Outcome. Geburtshilfe Frauenheilkd. 2015; 73(3):247-255. PMC: 4647484. DOI: 10.1055/s-0032-1328318. View

3.
Fruehauf J, Back W, Eiermann A, Lang M, Pessel M, Marlinghaus E . High-intensity focused ultrasound for the targeted destruction of uterine tissues: experiences from a pilot study using a mobile HIFU unit. Arch Gynecol Obstet. 2007; 277(2):143-50. DOI: 10.1007/s00404-007-0435-0. View

4.
Kamp J, David M, Scheurig-Muenkler C, Hengst S, Beck A . [Clinical outcome of magnetic-resonance-guided focused ultrasound surgery (MRgFUS) in the treatment of symptomatic uterine fibroids]. Rofo. 2012; 185(2):136-43. DOI: 10.1055/s-0032-1325512. View

5.
Kroncke T, David M . [Uterine artery embolization (UAE) for fibroid treatment: results of the 4th Radiological Gynecological Expert Meeting]. Rofo. 2013; 185(5):461-3. DOI: 10.1055/s-0033-1335339. View